Lantern Pharma LTRN
NASDAQ LTRN
$0.64 -0.03 (-4.05%)
At close: Oct 19, 2026 · 4:00 PM EDT

Lantern Pharma (LTRN) Receivables - Other (2019 - 2020)

Updated

Lantern Pharma (LTRN) posted Receivables - Other of $11,000 for Q4 2020, unchanged from $11,000 a year earlier and unchanged from the prior quarter.

Analysis

Lantern Pharma (LTRN) Receivables - Other (2019 - 2020) Analysis & Trends

Since Q4 2019, Lantern Pharma has reported Receivables - Other for 4 quarters.

  • In prior years, Lantern Pharma's Receivables - Other was $11,000 in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,109.83 Bn 1,078.42 Bn 19.71 Bn
2 Johnson & Johnson 610.61 Bn 529.14 Bn 17.26 Bn
3 AbbVie 500.66 Bn 473.77 Bn 12.70 Bn
4 Merck 354.64 Bn 309.02 Bn 12.21 Bn
5 Novartis Ag 291.14 Bn 255.13 Bn 11.24 Bn
6 Astrazeneca 254.18 Bn 227.87 Bn 12.86 Bn
7 Amgen 229.46 Bn 184.86 Bn 7.24 Bn
8 Gilead Sciences 190.33 Bn 164.53 Bn 6.22 Bn
9 Pfizer 167.92 Bn 114.57 Bn 10.94 Bn
10 Lantern Pharma 7.95 Mn -28.21 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 11,000.00
Sep 30, 2020 11,000.00
Jun 30, 2020 11,000.00
Dec 31, 2019 11,000.00
API Access

Lantern Pharma Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=LTRN&period=max&api_key=YOUR_API_KEY